Faculty in the Media
Maureen Lyon, PhD, professor of pediatrics, spoke to MD Magazine for an article discussing her recent study on the impacts of advance care planning on HIV symptoms in teens.
Daniel Lieberman, MD, professor of psychiatry and behavioral sciences, spoke to Washingtonian for an article about the anxiety the New York Times election ticker can cause people.
Daniel Lieberman, MD, professor of psychiatry and behavioral sciences, was on Good Morning Washington (ABC7) to discuss the role dopamine plays in politics and to promote his new book, Molecule of More.
Eric Vilain, MD, PhD, chair of the Department of Genomics and Precision Medicine, spoke to Wired for an article about the U.S. Department of Health and Human Services' memo on defining a person's sex under Title IX.
Roberta DeBiasi, MD, professor of pediatrics, spoke with Axios for an article about acute flaccid myelitis, a polio-like illness that has left some children with partial paralysis or muscle weakness.
Lisa Alexander, EdD '03, MPH '89, PA-C '79, professor of physician assistant studies, addressed opioid use disorder at the symposium, titled “Expanding Access to Treatment for Opioid Use Disorder: Provider Perspectives on Reducing Barriers to Evidence-Based Care.” Her comments were reported by the…
Jehan "Gigi" El-Bayoumi, MD, founding director of the GW Rodham Institute and professor of medicine, spoke with NBC4 about Ruth Rucker and her legacy as a champion for health equity in Washington, D.C.
Nathaniel DeNicola, MD, assistant professor of obstetrics and gynecology, spoke to The Wall Street Journal for an article about keeping a baby's gender a mystery until birth.
Adam Friedman, MD, professor of dermatology, spoke to WUSA9 for a segment about the side effects of cancer and how clinics like GW's Supportive Oncodermatology Clinic can help.
Catherine Bollard, MD, associate center director for translational research and innovation at GW Cancer Center, was quoted by Interesting Engineering in an article about her recent study looking at the safety of a cell therapy involving expanding T-cells against HIV.